Business Segments · Segment net sales
Life Sciences and Emerging Growth Businesses — Segment net sales
Corning Life Sciences and Emerging Growth Businesses — Segment net sales remained flat by 0.0% to $272M in Q1 2026 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2025
Last reportedQ1 2026May 1, 2026
How to read this metric
An increase suggests successful product adoption and market expansion, while a decrease may indicate slowing demand or product lifecycle maturity.
Detailed definition
This metric represents the total revenue generated by the Life Sciences and Emerging Growth segment, which focuses on la...
Peer comparison
Comparable to revenue metrics for specialized life science tools or R&D-heavy business units in diversified industrial firms.
Metric ID:
glw_segment_life_sciences_and_emerging_growth_businesses_segment_net_salesHistorical Data
2 periods
| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | $272M | $272M |
| QoQ Change | — | +0.0% |
| YoY Change | — | +0.0% |
Range$272M – $272M
Avg YoY Growth+0.0%
Median YoY Growth+0.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Corning's life sciences and emerging growth businesses — segment net sales?
- Corning (GLW) reported life sciences and emerging growth businesses — segment net sales of $272M in Q1 2026.
- What does life sciences and emerging growth businesses — segment net sales mean?
- Total revenue earned from the Life Sciences and Emerging Growth business segment.